Who is sponsoring NCT03543345?

NCT03543345 is sponsored by Assiut University.

What drugs are being tested in NCT03543345?

Interventions in NCT03543345: echocardiography study.

What condition does NCT03543345 study?

NCT03543345 studies Right Coronary Artery Occlusion.

Is NCT03543345 still recruiting?

NCT03543345 is currently status unknown. Last updated 19 June 2018.

Last reviewed 2018-06-19 · How we verify

NCT03543345

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Right Ventricular Function Change After PCI to Right Coronary Artery

Status unknown Last updated 19 June 2018

What this trial tests

trial testing echocardiography study in Right Coronary Artery Occlusion in 50 participants. Status unknown.

Timeline

1 June 2018

Primary endpoint
15 August 2018

28 August 2018

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 June 2018
Primary completion	15 August 2018
Estimated completion	28 August 2018
Sites	1 location across Egypt

Drugs / interventions tested

echocardiography study

Conditions studied

Right Coronary Artery Occlusion — all drugs for Right Coronary Artery Occlusion →

Sponsor

Assiut University

Who can join

Adults 40 to 75, any sex, with Right Coronary Artery Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proximal RCA occlusions were very often found among men with fatal pre-hospital MI; whereas left-sided coronary occlusions were significantly more frequent in hospital-admitted survivors of MI. Left-sided coronary occlusions may be associated with a more favorable pre-hospital phase of acute MI compared to proximal RCA occlusions. Proximal RCA occlusion increases the risk of arrhythmia and shock leading to increase the mortality. Sinus bradycardia and cardiogenic shock accounts for the majorities of the mortalities of RCA occlusion

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03543345 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 19 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543345.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing